A Precision Randomized Trial of Hepatitis C Treatment Adherence Support Among 3000 PWID in India
Background: HCV elimination is unlikely without curing people who inject drugs (PWID). Many PWID will need additional support to achieve HCV cure, but resources are limited, particularly in low-and-middle-income countries. A precision approach could improve the efficiency of intervention delivery. The STOP-C trial evaluated whether HCV treatment outcomes could be optimized by tailoring adherence support…